HuGE Literature Finder
Records
1
-
30
| Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension. Pharmacogenomics and personalized medicine 2021 14 189-197. Liang Hao, Zhang Xinru, Ma Zhuo, Sun Yan, Shu Chang, Zhu Yihua, Zhang Yanwei, Hu Songnian, Fu Xiujuan, Liu Liho |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Incorporation of Gene-Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients. Journal of clinical pharmacology 2019 Mar . Tang Jie, Xu Jing, Zhang Yue-Li, Liu Rong, Liu Mou-Ze, Hu Yong-Fang, Shao Ming-Jie, Zhu Li-Jun, Cao Shan, Xin Hua-Wen, Feng Gui-Wen, Shang Wen-Jun, Meng Xiang-Guang, Zhang Li-Rong, Ming Ying-Zi, Zhang Wei, Zhou G |
| A new donors' CYP3A5 and recipients' CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients. Oncotarget 2017 Sep 8 (41): 70250-70261. Liu Yuan, Zhang Tao, Zhang Xiaoqing, Ye Ling, Gu Haitao, Zhong Lin, Sun Hongcheng, Song Chenlong, Peng Zhihai, Fan Junw |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| Association between CYP3A5 genotypes with hypertension in Chinese Han population: A case-control study. Clinical and experimental hypertension (New York, N.Y. : 1993) 2017 39 (3): 235-240. Li Zhanzhan, Chen Peng, Zhou Tao, Chen Xiaofang, Chen Lizha |
| CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population. Journal of human hypertension 2016 Dec 30 (12): 778-782. Fisher D L, Plange-Rhule J, Moreton M, Eastwood J B, Kerry S M, Micah F, Johnston A, Cappuccio F P, MacPhee I A |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation?. International journal of clinical pharmacology and therapeutics 2016 Nov . Huang Yun, Wen Gaiyan, Lu Yao, Wen Jia, Ji Ying, Xing Xiaowei, Li Ying, Wen Juan, Yuan Ho |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke. Gene 2015 Jul 565 (1): 85-9. Yi Xingyang, Zhang Biao, Wang Chun, Liao Duanxiu, Lin Jing, Chi Lif |
| Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients. Biomedical reports 2015 Mar 3 (2): 195-200. Guo Chengxian, Pei Q I, Tan Hongyi, Huang Zhijun, Yuan Hong, Yang Guopi |
| Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. Genetics and molecular research : GMR 2015 14 (2): 3191-9. Wang L, Li N, Wang M X, Lu S |
| Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese. Neuroreport 2014 May 25 (7): 452-7. Chi Li-Fen, Yi Xing-Yang, Shao Min-Jie, Lin Jing, Zhou Qia |
| ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis. Drug metabolism and pharmacokinetics 2014 29 (4): 305-11. Zuo Xiao-cong, Zhang Wen-li, Yuan Hong, Barrett Jeffrey S, Hua Ye, Huang Zhi-jun, Zhou Hong-hao, Pei Qi, Guo Cheng-xian, Wang Jiang-lin, Yang Guo-pi |
| Hypertension-susceptibility gene prevalence in the Pacific Islands and associations with hypertension in Melanesia. Journal of human genetics 2013 Mar 58 (3): 142-9. Furusawa Takuro, Naka Izumi, Yamauchi Taro, Natsuhara Kazumi, Eddie Ricky, Kimura Ryosuke, Nakazawa Minato, Ishida Takafumi, Inaoka Tsukasa, Matsumura Yasuhiro, Ataka Yuji, Ohtsuka Ryutaro, Ohashi J |
| Association between urinary 6ß-hydroxycortisol/cortisol ratio and CYP3A5 genotypes in a normotensive population. Experimental and therapeutic medicine 2013 Feb 5 (2): 527-532. Rais Naushad, Hussain Arif, Chawla Yogesh Kumar, Kohli Krishan |
| Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. Transplantation proceedings 2012 Nov 44 (9): 2596-8. Torio A, Auyanet I, Montes-Ares O, Guerra R M, Fernandez E J, Perez M A, Ramirez A, Checa M |
| Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. Transplantation 2012 Apr 93 (8): 806-12. Hooper David K, Fukuda Tsuyoshi, Gardiner Rhonda, Logan Barbara, Roy-Chaudhury Ashwini, Kirby Cassie L, Vinks Alexander A, Goebel Je |
Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.
PLoS genetics 2012 8 (10): e1003005. Krumsiek Jan, Suhre Karsten, Evans Anne M, Mitchell Matthew W, Mohney Robert P, Milburn Michael V, Wägele Brigitte, Römisch-Margl Werner, Illig Thomas, Adamski Jerzy, Gieger Christian, Theis Fabian J, Kastenmüller Ga |
| Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy. American journal of cardiovascular drugs : drugs, devices, and other interventions 2011 Dec 11 (6): 401-9. Cai Jingjing, Huang Zhijun, Yang Guoping, Cheng Ke, Ye Qifa, Ming Yingzi, Zuo Xiaocong, Zhou Peipei, Yuan Ho |
| Association of the CYP3A5 polymorphism (6986G>A) with blood pressure and hypertension. Hypertension research : official journal of the Japanese Society of Hypertension 2011 Nov 34 (11): 1216-20. Xi Bo, Wang Chunyu, Liu Liu, Zeng Tao, Liang Yajun, Li Jun, Mi J |
| Pharmacokinetics of bosentan in routinely treated Japanese pediatric patients with pulmonary arterial hypertension. Drug metabolism and pharmacokinetics 2011 Jun 26 (3): 280-7. Taguchi Masato, Ichida Fukiko, Hirono Keiichi, Miyawaki Toshio, Yoshimura Naoki, Nakamura Tsuneyuki, Akita Chisato, Nakayama Tomotaka, Saji Tsutomu, Kato Yuya, Horiuchi Isao, Hashimoto Yuki |
| Design of Allele Specific PCR for Rapid Detection of CYP3A5 (A6986G) and Mdr-1 (C3435T) Polymorphisms. Indian journal of clinical biochemistry : IJCB 2011 Jan 26 (1): 18-21. Ashavaid Tester F, Raje Himanshu S, Shah Bharat V, Shah Swarup |
| Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors. Clinical and experimental hypertension (New York, N.Y. : 1993) 2011 33 (6): 359-65. Ferraresso Mariano, Turolo Stefano, Ghio Luciana, Tirelli Amedea S, Belingheri Mirco, Villa Roberta, Groppali Elena, Edefonti Alber |
| [A cross-racial analysis on the susceptible gene polymorphisms of salt-sensitive hypertension]. Zhonghua xin xue guan bing za zhi 2010 Oct 38 (10): 943-8. Lu Jia-peng, Zhang Ling, Wang W |
| Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy. Biochemical and biophysical research communications 2010 Jul 397 (3): 576-9. Coto Eliecer, Tavira Beatriz, Marín Rafael, Ortega Francisco, López-Larrea Carlos, Ruiz-Ortega Marta, Ortiz Alberto, Díaz Marta, Corao Ana I, Alonso Belén, Alvarez Victor |
| CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease. American journal of nephrology 2010 31 (2): 95-103. Bhatnagar Vibha, Garcia Erin P, O'Connor Daniel T, Brophy Victoria H, Alcaraz John, Richard Erin, Bakris George L, Middleton John P, Norris Keith C, Wright Jackson, Hiremath Leena, Contreras Gabriel, Appel Lawrence J, Lipkowitz Michael S, |
| Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2008 Jun 18 (6): 507-14. Kamdem Landry K, Hamilton Leo, Cheng Cheng, Liu Wei, Yang Wenjian, Johnson Julie A, Pui Ching-Hon, Relling Mary |
| Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation. Clinical transplantation 0 24 (6): 855-61. Yanagimachi Masakatsu, Naruto Takuya, Tanoshima Reo, Kato Hiromi, Yokosuka Tomoko, Kajiwara Ryosuke, Fujii Hisaki, Tanaka Fumiko, Goto Hiroaki, Yagihashi Tatsuhiko, Kosaki Kenjiro, Yokota Shump |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 18, 2022
- Content source: